CBD Suppressed Immune Responses and Antibody Production in Mice | Research

The takeaway

A single dose of CBD before allergen exposure significantly reduced antibody production and immune cell activity in mice, suggesting potent immunosuppressive effects.

Read this if you're interested in how CBD affects the immune system beyond its anti-inflammatory reputation.

All CBD doses (5-20 mg/kg) suppressed antibody production in sensitized mice

What the researchers found

Mice received a single dose of CBD (5-20 mg/kg) before being sensitized with ovalbumin (a common allergen used in immunology research). Seven days later, researchers measured immune responses.

The highest CBD dose (20 mg/kg) significantly reduced IgM antibody levels, while all three doses (5, 10, and 20 mg/kg) suppressed IgG1 and IgG2a antibody production. Immune cells from CBD-treated mice produced less IL-2, IL-4, and IFN-gamma when stimulated, and T-cell proliferation was markedly suppressed.

Importantly, these effects were confirmed both in vivo (in the living mice) and in vitro (when immune cells were directly exposed to CBD), demonstrating a direct immunosuppressive action rather than an indirect systemic effect.

Why it matters

This study provided dose-response evidence that CBD has significant immunosuppressive properties. While this could be beneficial for autoimmune conditions or allergies, it also raises questions about whether regular CBD use might compromise normal immune function.

The numbers in context

CBD 20 mg/kg suppressed IgM production. All doses (5, 10, 20 mg/kg) suppressed IgG1 and IgG2a. Splenocyte proliferation and cytokine production (IL-2, IL-4, IFN-gamma) were markedly reduced at 5 and 20 mg/kg.

How the study worked

BALB/c mice received a single intraperitoneal dose of CBD (5, 10, or 20 mg/kg) before ovalbumin sensitization. Serum antibodies were measured 7 days later. Splenocyte function was assessed through cytokine production and proliferation assays both ex vivo and in vitro.

What this study cannot tell us

This was a mouse study using intraperitoneal injection, a route not used by humans taking CBD. A single dose before sensitization is a specific scenario that may not reflect typical CBD use patterns. The ovalbumin model is standard but may not predict effects on natural immune challenges.

How to read the evidence

This is an animal study using a standard immunological model. Results demonstrate clear dose-response effects but require human validation.

When this study was published

Published in 2007. Research on CBD's immunomodulatory effects has continued, though comprehensive human immune function studies remain limited.

The bigger picture

This study added to the growing evidence that CBD has meaningful immunomodulatory effects beyond the commonly discussed anti-inflammatory properties. The suppression of both Th1 (IFN-gamma) and Th2 (IL-4) cytokines suggests broad immune suppression rather than selective modulation.

Questions still open

Could chronic CBD use in humans meaningfully suppress immune responses to infections or vaccines? Would oral CBD at typical human doses produce similar immunosuppression?

Common questions

Could CBD weaken my immune system?

This mouse study showed significant immune suppression from CBD, but the doses and route of administration differ greatly from typical human CBD use. Whether oral CBD at common doses affects human immune function meaningfully remains unclear.

Could immune suppression be beneficial?

Yes, in certain conditions. Autoimmune diseases and allergies involve overactive immune responses. If CBD can selectively reduce harmful immune activity without leaving people vulnerable to infections, it could be therapeutically useful.

Read the original research

Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice.

International immunopharmacology, 7(6), 773-80

View on PubMed ↗

Citation

Jan, Tong-Rong; Su, Shu-Ting; Wu, Hsin-Ying; Liao, Mei-Hsiu. (2007). Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice.. International immunopharmacology, 7(6), 773-80.